ScienceDaily (Oct. 28, 2008) — Scientists from the Scripps Research Institute have discovered a catalytic antibody that degrades a known appetite stimulant. The antibody works against the gastric hormone ghrelin (pronounced “grell-in”), which has been linked to weight gain and fat storage through its metabolic actions. These findings point towards a potentially novel treatment for obesity that would interfere directly with the some of the biological mechanisms determining weight.
